The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer. - Arriaga-Canon C; De La Rosa-Velázquez IA; González-Barrios R; Montiel-Manríquez R; Oliva-Rico D; Jiménez-Trejo F; Cortés-González C; Herrera LA (Oncotarget, 2018)